In 2011, new legislation came into force in July 2011. It contains a list (schedule e) of raw materials and products with a supposed effect similar to controlled drugs  (see here). In December 2011, generic definitions of synthetic cathinones, naphthylpyrovalerones and related compounds, and five groups of synthetic cannabinoids were added to the legislation as well as a list of specific NPS, including several JWH-compounds, aminoindanes, etc.

In December 2012, more NPS were added to schedule, among them 2C-C, NBOMe compounds (25C-NBOMe, 25I-NBOMe), several AM-compounds, MAM-2201, A-796,260, A-836,339, AKB-48, CB-13, UR-144, STS-135, XLR-11, URB-597, URB-754, 4-AcO-DALT, 4-AcO-DET, 4-AcO-DIPT, 4-AcO-DPT, 4-HO-MET, 4-HO-MIPT, 4-MeO-MiPT, 5-MeO-MiPT, 5-MeO-DiPT, 5-MeO-DMT, 5-MeO-DALT, ethylphenidate, 4-Fluorotropacocaïne, pFBT, mFBT, oFBT, 4-MA, 3-MA, MBZP, 5-APDB, 6-APDB, JWH- 018 Adamantyl carboxamide, APICA, 4-MeO-PCP, 3-MeO-PCP. 

In December 2013, additional NPS were placed under control:PB22; BB22; 5F-PB22; 5F-AKB48; 25B-NBOMe; 25D-NBOMe; 4-Bromamphetamine; 3-Bromamphetamine; 2-Bromamphetamine; W-15; HU-210; WIN-55,212-2; AB-FUBINACA; AB-PINACA; AH-7921; 5-MAPB; 6-MAPB; 5-EAPB; 6-EAPB; 4-HO-DET; RH-34; N-ethyl-norketamine; 3,4-dichloromethylphenidate; 5-IT (see here).

In December 2014, a generic definition for phenethylamines was introduced in the legislation (see here).